Literature DB >> 10397415

Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.

C C Bow-Thomas1, D I Velligan, A L Miller, J Olsen.   

Abstract

There has been little research investigating how symptoms of schizophrenia and changes in symptomatology across the course of the illness relate to measures of quality of life in patients. We examined this issue in 45 patients assessed at hospital admission for illness exacerbation, at stabilization (prior to discharge) and at follow-up (5-9 months post-discharge). Symptom ratings at each time period consisted of the Brief Psychiatric Rating Scale (BPRS) and the Negative Symptom Assessment (NSA). The Heinrichs-Carpenter Quality of Life Scale (QLS) was administered upon admission to the hospital (assessing the 3 months prior to admission) and again at follow-up. Correlational analyses revealed relationships of both positive and negative symptoms with quality of life. These relationships are particularly strong at stabilization. Stepwise regression analyses revealed changes in the NSA motivation component to be most important in predicting quality of life for the patients at follow-up. BPRS psychosis and paranoia components are important predictors of quality of life at stabilization (but not during acute exacerbation). These results are important in terms of understanding the impact of changes in symptomatology on the quality of life for patients with schizophrenia as well as in targeting specific symptom clusters for treatment to maximize quality of life post-hospitalization.

Entities:  

Mesh:

Year:  1999        PMID: 10397415     DOI: 10.1016/s0165-1781(99)00023-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  25 in total

1.  Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia.

Authors:  C W Law; Eric Y H Chen; Eric F C Cheung; Raymond C K Chan; Josephine G W S Wong; Cindy L K Lam; K F Leung; Molly S M Lo
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

3.  Subjective and objective quality of life in schizophrenia.

Authors:  Jenille M Narvaez; Elizabeth W Twamley; Christine L McKibbin; Robert K Heaton; Thomas L Patterson
Journal:  Schizophr Res       Date:  2007-10-04       Impact factor: 4.939

4.  An industry perspective on the NIMH consensus statement on negative symptoms.

Authors:  Larry Alphs
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

5.  Determinants of changes in perceived quality of life in the course of schizophrenia.

Authors:  Michael Ritsner; Anatoly Gibel; Yael Ratner
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

6.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors.

Authors:  Michael S Ritsner; Alexander Lisker; Marina Arbitman
Journal:  Qual Life Res       Date:  2011-09-13       Impact factor: 4.147

7.  Sexual orientation and quality of life among students of Obafemi Awolowo University (OAU), Nigeria.

Authors:  Mapayi Boladale; Oginni Olakunle; Aloba Olutayo; Akinsulore Adesanmi
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

8.  Cognitive motivational systems and life satisfaction in serious and persistent mental illness.

Authors:  Iruma Bello; John J Steffen; Kentaro Hayashi
Journal:  Qual Life Res       Date:  2011-01-25       Impact factor: 4.147

9.  Measurement of quality of life in schizophrenia: a comparison of two scales.

Authors:  Yvette Kusel; Richard Laugharne; Sian Perrington; Jan McKendrick; Deborah Stephenson; J Stockton-Henderson; Madeline Barley; R McCaul; Tom Burns
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-08-29       Impact factor: 4.328

Review 10.  Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Authors:  Martin Lambert; Dieter Naber
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.